CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

Go back to CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.82 +0.15 (1.73%)
Previous Close $8.67    52 Week High $4.54 
Open $8.70    52 Week Low $1.15 
Day High $9.06    P/E N/A 
Day Low $8.70    EPS $-0.55 
Volume 1,957,729